Several statistical analyses showed that SKP2 promotes the progression and induces tumorigenesis of nasopharyngeal carcinoma (Yu et al., 2019) and accelerates the growth of renal cell carcinoma (Chen et al., 2021). The gene discussed is SKP2; the disease is nasopharyngeal carcinoma.